Company
|
||||||
---|---|---|---|---|---|---|
AbbVie
ABBV
|
NYSE
|
USA
|
Healthcare
|
231.54
$
|
5.55
%
|
315.06B
$
|
Amgen
AMGN
|
NASDAQ
|
USA
|
Healthcare
|
282.2
$
|
5.78
%
|
141.01B
$
|
Gilead Sciences
GILD
|
NASDAQ
|
USA
|
Healthcare
|
111
$
|
0.14
%
|
115.92B
$
|
Vertex Pharmaceuticals
VRTX
|
NASDAQ
|
USA
|
Healthcare
|
391.64
$
|
3.21
%
|
103.86B
$
|
![]()
Genus PLC
GNS
|
LSE
|
UK
|
Healthcare
|
2.37K
£
|
4.64
%
|
102.57B
£
|
Regeneron Pharmaceuticals
REGN
|
NASDAQ
|
USA
|
Healthcare
|
562.27
$
|
6.7
%
|
81.99B
$
|
PROMOMED
PRMD
|
MOEX
|
Russia
|
Healthcare
|
381.8
₽
|
-0.93
%
|
72.82B
₽
|
![]()
PureTech Health plc
PRTC
|
LSE
|
UK
|
Healthcare
|
139
£
|
4.51
%
|
40.5B
£
|
![]()
argenx NV ADR
ARGX
|
NASDAQ
|
USA
|
Healthcare
|
767.33
$
|
4.04
%
|
40.08B
$
|
Alnylam Pharmaceuticals
ALNY
|
NASDAQ
|
USA
|
Healthcare
|
456
$
|
1.02
%
|
30.04B
$
|
![]()
BioNTech SE
BNTX
|
NASDAQ
|
USA
|
Healthcare
|
98.62
$
|
3.64
%
|
27.37B
$
|
Biodexa Pharmaceticals
BDRX
|
NASDAQ
|
USA
|
Healthcare
|
6.65
$
|
-0.6
%
|
27.08B
$
|
Biogen
BIIB
|
NASDAQ
|
USA
|
Healthcare
|
140.08
$
|
10.09
%
|
22.31B
$
|
Natera
NTRA
|
NASDAQ
|
USA
|
Healthcare
|
160.97
$
|
0.4
%
|
19.74B
$
|
BeiGene, Ltd.
ONC
|
NASDAQ
|
USA
|
Healthcare
|
340.7
$
|
-1.63
%
|
19.45B
$
|
4BASEBIO UK SOCIETAS
4BB
|
LSE
|
UK
|
Healthcare
|
775
£
|
-2.52
%
|
18.72B
£
|
United Therapeutics
UTHR
|
NASDAQ
|
USA
|
Healthcare
|
419.21
$
|
4.53
%
|
17.11B
$
|
![]()
Avacta Group PLC
AVCT
|
LSE
|
UK
|
Healthcare
|
61.5
£
|
3.36
%
|
16.35B
£
|
Moderna
MRNA
|
NASDAQ
|
USA
|
Healthcare
|
25.83
$
|
6.85
%
|
15.97B
$
|
Royalty Pharma Plc
RPRX
|
NASDAQ
|
USA
|
Healthcare
|
35.28
$
|
2.95
%
|
15.12B
$
|